Our mechanistic studies in HFD-induced NAFLD mice potentially implied that PNS supplementation improved hepatic steatosis and fibrosis via inhibition of hepatic CD14 and TLR4 activation. This evidence concerns the gene CD14 and metabolic dysfunction-associated steatotic liver disease.